KBP BIOSCIENCES Overview
Upcoming Projects (KBP BIOSCIENCES)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KBP BIOSCIENCES)
-
A second look at the developing treatment landscape for resistant hypertension, including Baxdrostat and Ocedurenone
Tickers: CINC, KBP Biosciences
Executed On: Aug 03, 2022 at 10:00 AM EDT -
A look at the developing treatment landscape for resistant hypertension, including Baxdrostat and Ocedurenone
Tickers: CINC, KBP Biosciences
Executed On: Jul 26, 2022 at 04:00 PM EDT -
A second look at Idorsia's phase III trials results for its resistant hypertension drug, Aprocitentan
Tickers: IDRSF, CINC, AZN, KBP Biosciences
Executed On: Jul 06, 2022 at 01:30 PM EDT
Upcoming & Overdue Catalysts (KBP BIOSCIENCES)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KBP BIOSCIENCES)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
